My watch list
my.chemeurope.com  
Login  

Sphingomyelinases are a group of hydrolases that cleave sphingomyelin, a common component of plasma membranes, to form ceramide and phosphocholine. Ceramide is a second messenger that is present in virtually all cell types and regulates a variety of cellular functions such as proliferation, differentiation, apoptosis, and inflammation response. Inhibition of sphingomyelinase activity to reduce ceramide concentrations has recently emerged as a potential therapeutic approach for several diseases including atherosclerosis, pathogen infections, inflammation, diabetes, and obesity. To effectively screen compound collections for the identification of new sphingomyelinase inhibitors, we have developed a high-throughput assay utilizing the natural substrate sphingomyelin in 1,536-well plate format. The assay has a signal-to-basal ratio of 6.1-fold in pH 5.0 buffer and 4.3-fold in pH 6.5 buffer, indicating a robust assay for compound library screening. A screen of ~300,000 compounds using this assay led to the identification of eight compounds as sphingomyelinase inhibitors (IC50s = 1.7 to 38.2 μM) that exhibited different activities between the natural substrate assay and profluorescence substrate assay. The results demonstrate the robustness and effectiveness of the natural substrate sphingomyelinase assay for screening sphingomyelinase inhibitors.

Authors:   Miao Xu, Ke Liu, Noel Southall, Juan J. Marugan, Alan T. Remaley, Wei Zheng
Journal:   Analytical and Bioanalytical Chemistry
Year:   2012
DOI:   10.1007/s00216-012-6174-5
Publication date:   19-06-2012

Watchlist

This is where you can add this publication to your personal favourites.

Additional Information

More about Springer-Verlag
Contact
Springer-Verlag GmbH
Tiergartenstraße 17
69121 Heidelberg
Germany
Phone
++49 / (0)6221 / 487-0
Fax
++49 / (0)6221 / 413982
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE